New Providence Acquisition Corp IIIの流動比率は0、純利益率は0、1株当たり売上高は$0です。
New Providence Acquisition Corp IIIの収益はセグメントまたは地域別にどのように分けられていますか?
New Providence Acquisition Corp III の最大収益セグメントは Biopharmaceutical Products で、最新の利益発表における収益は 13,996,000 です。地域別に見ると、United States が New Providence Acquisition Corp III の主要市場であり、収益は 13,996,000 です。
New Providence Acquisition Corp IIIの総発行済株式数は33.47株です。
主要データ
前終値
$10.38
始値
$10.32
当日レンジ
$10.32 - $10.38
52週レンジ
$9.98 - $10.87
取引高
84
平均取引高
5.4K
配当利回り
--
1株当たり利益(TTM)
--
時価総額
$398.4M
NPACUとは何ですか?
New Providence Acquisition Corp. III is a blank check company. The company is headquartered in Austin, Texas. The company went IPO on 2025-04-24. The firm is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The firm has not selected any business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. The firm may pursue an initial business combination in any business or industry. The firm has conducted no operations and has generated no revenues.